Overcoming segmentation errors in measurements of macular thickness made by spectral-domain optical coherence tomography

Retina

Volumn 32, Issue 3, 2012, Pages 569-580

  Song, Yumi ^a   Lee, Byung Ro ^a   Shin, Yong Woon ^a   Lee, Yoon Jung ^a  

^a Hanyang University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MACULAR THICKNESS; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MEASUREMENT ERROR; OPTICAL COHERENCE TOMOGRAPHY; RETINA DISEASE; RETINA MACULA LUTEA; THREE DIMENSIONAL IMAGING;

ADULT; AGED; CLINICAL PROTOCOLS; DIAGNOSTIC ERRORS; EYE DISEASES; FEMALE; HUMANS; MACULA LUTEA; MACULAR DEGENERATION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84858082266     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0b013e31821f5d69     Document Type: Article

References (23)

1. Huang D, Swanson EA, Lin CP, et al. Optical coherence tomography. Science 1991;254:1178-1181. (Pubitemid 21917444)
2. Fung AE, Lalwani GA, Rosenfeld PJ, et al. An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration. Am J Ophthalmol 2007;143:566-583.
3. Emerson MV, Lauer AK, Flaxel CJ, et al. Intravitreal bevacizumab (Avastin) treatment of neovascular age-related macular degeneration. Retina 2007;27:439-444. (Pubitemid 46624283)
4. Boyer DS, Heier JS, Brown DM, et al. A phase IIIb study to evaluate the safety of ranibizumab in subjects with neovascular age-related macular degeneration. Ophthalmology 2009;116: 1731-1739.
5. Arevalo JF, Fromow-Guerra J, Sanchez JG, et al; Pan-American Collaborative Retina Study Group. Primary intravitreal bevacizumab for subfoveal choroidal neovascularization in age-related macular degeneration: results of the Pan-American Collaborative Retina Study Group at 12 months follow-up. Retina 2008;28:1387-1394.
6. Arevalo JF, Sanchez JG, Wu L, et al; Pan-American Collaborative Retina Study Group. Primary intravitreal bevacizumab for diffuse diabetic macular edema: the Pan- American Collaborative Retina Study Group at 24 months. Ophthalmology 2009;116:1488-1497.
7. Ip MS, Oden NL, Scott IU, et al; SCORE Study Investigator Group. SCORE Study report 3: study design and baseline characteristics. Ophthalmology 2009;116:1770-1777.
8. Keane PA, Liakopoulos S, Jivrajka RV, et al. Evaluation of optical coherence tomography retinal thickness parameters for use in clinical trials for neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci 2009;50:3378-3385.
9. Domalpally A, Danis RP, Zhang B, et al. Quality issues in interpretation of optical coherence tomograms in macular diseases. Retina 2009;29:775-781.
10. Taban M, Sharma S, Williams DR, et al. Comparing retinal thickness measurements using automated fast macular thickness map versus six-radial line scans with manual measurements. Ophthalmology 2009;116:964-970.
11. Drexler W, Sattermann H, Hermann B, et al. Enhanced visualization of macular pathology with the use of ultrahighresolution optical coherence tomography. Arch Ophthalmology 2003;121:695-706. (Pubitemid 36554473)
12. Wojtkowski M, Srinivasan VJ, Ko TH, et al. Ultrahighresolution, high-speed, Fourier domain optical coherence tomography and methods for dispersion compensation. Opt Express 2004;12:2404-2222.
13. Ho J, Sull AC, Vuong LN, et al. Assessment of artifacts and reproducibility across spectral- and time-domain optical coherence tomography devices. Ophthalmology 2009;116:1960-1970.
14. Keane PA, Mand PS, Liakopoulos S, et al. Accuracy of retinal thickness measurements obtained with Cirrus optical coherence tomography. Br J Ophthalmol 2009;93:1461-1467.
15. Han IC, Jaffe GJ. Evaluation of artifacts associated with macular spectral-domain optical coherence tomography. Ophthalmology 2010;117:1177-1189.
16. World Medical Association. Declaration of Helsinki: Ethical Principals for Research Involving Human Subjects. As amended in Seoul, 2008. Available at: http://www.wma.net/en/30publications/10policies/b3/index.html. Accessed December 14, 2009.
17. Sadda SR, Wu Z, Walsh AC, et al. Errors in retinal thickness measurements obtained by optical coherence tomography. Ophthalmology 2006;113:285-293. (Pubitemid 43170778)
18. Ray R, Stinnett SS, Jaffe GJ. Evaluation of image artifact produced by optical coherence tomography of retinal pathology. Am J Ophthalmol 2005;139:18-29. (Pubitemid 40094836)
19. Ghazi NG, Kirk T, Allam S, Yan G. Quantification of error in optical coherence tomography central macular thickness measurement in wet age-related macular degeneration. Am J Ophthalmol 2009;148:90-96.
20. Patel PJ, Chen FK, Cruz L, Tufail A. Segmentation error in Stratus optical coherence tomography for neovascular agerelated macular degeneration. Invest Ophthalmol Vis Sci 2009; 50:399-404.
21. Forte R, Cennamo GL, Finelli ML, de Crecchio G. Comparison of time domain Stratus OCTand spectral domain SLO/OCT for assessment of macular thickness and volume. Eye 2009;23: 2071-2078.
22. Leung W, Chan K, Chong K, et al. Alignment artifacts in optical coherence tomography analyzed images. Ophthalmology 2007;114:263-270. (Pubitemid 46161790)
23. Sayanagi K, Sharma S, Kaiser PK. Comparison of retinal thickness measurements between three-dimensional and radial scans on spectral-domain optical coherence tomography. Am J Ophthalmol 2009;148:431-438.